⌘K

Login Start Free

Home/Filings/4/0001209191-19-031833

4//SEC Filing

Mow Jonathan P 4

Accession 0001209191-19-031833

CIK 0001169245other

View on SEC.gov Company Profile

Filed

May 20, 8:00 PM ET

Accepted

May 21, 6:27 PM ET

Size

10.7 KB

Accession

0001209191-19-031833

Insider Transaction Report

Form 4

Period: 2019-05-17

PhaseBio Pharmaceuticals IncPHAS

DirectorChief Executive Officer

Transactions

Exercise/Conversion
Common Stock
2019-05-17$2.27/sh+19,913$45,203→ 71,112 total
Exercise/Conversion
Common Stock
2019-05-20$1.24/sh+19,131$23,722→ 90,243 total
Exercise/Conversion
Employee stock option (right to buy)
2019-05-17−19,913→ 0 total
Exercise: $2.27From: 2016-12-03Exp: 2022-12-21→ Common Stock (19,913 underlying)
Exercise/Conversion
Employee stock option (right to buy)
2019-05-20−19,131→ 0 total
Exercise: $1.24From: 2018-03-14Exp: 2024-03-31→ Common Stock (19,131 underlying)

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

PhaseBio Pharmaceuticals Inc

CIK 0001169245

Entity typeother

Related Parties

1

filerCIK 0001313942

Filing Metadata

Form type: 4
Filed: May 20, 8:00 PM ET
Accepted: May 21, 6:27 PM ET
Size: 10.7 KB

View on SEC.gov